ST. LOUIS, MO (August 29, 2019) – Vetio is excited to announce that Chuck Berra has joined the company as Vice President of Sales, where he will lead all sales efforts. Vetio is a CDMO offering a wide range of services, including product development, analytical services, and commercial manufacturing of veterinary drugs. With new investments in capacity and expanded capabilities for both the Montreal and Jupiter plants, Vetio is well positioned for continued growth.
Chuck brings nearly two decades of Animal Health experience to Vetio. He has held positions most recently with Kindred Bio as National Sales Manager, Elanco Animal Health, and Ceva Animal Health.
Mike Smith will assume the new role of Vice President of Business Development. He will maintain responsibility for key accounts and bring additional focus to strategic commercial initiatives.
John Kane, CEO of Vetio, commented “We are excited to add Chuck to the executive team. He is a lifelong animal health executive and brings tremendous energy and industry experience to our team.”
Vetio (www.vetio.com) is a Contract Development and Manufacturing Organization (CDMO) that specializes in complex drug product formulation and manufacturing of veterinary pharmaceutical products. The company integrates product development with full-scale manufacturing through a Quality by Design-based process. Vetio is committed to the development and manufacturing of products that improve the lives of animals, while assuring the safety, quality and compliance of our products to the highest industry standards. With facilities in Jupiter, Florida and Montreal, Quebec, Vetio is the largest CDMO dedicated to Animal Health in North America. For more information, please contact Chuck Berra, VP Sales, firstname.lastname@example.org.